Statistics at a glance, 2022
Top 5 most frequent cancers Number of new cases
408 661
Number of deaths
242 988
Number of prevalent cases (5-year)
1 018 110
Males Females Both sexes
Population 140 508 390 138 626 115 279 134 505
Incidence
Number of new cancer cases 188 395 220 266 408 661
Age-standardized incidence rate 135.5 141.6 136.9
Risk of developing cancer before the age
of 75 years (cum. risk %) 14.1 14.0 14.0
Top 3 leading cancers (ranked by
cases) Lung
Colorectum Liver
Breast Cervix uteri Ovary
Breast Lung Cervix uteri
Mortality
Number of cancer deaths 128 740 114 248 242 988
Age-standardized mortality rate 93.9 73.9 82.5
Risk of dying from cancer before the age
of 75 years (cum. risk %) 9.9 7.9 8.8
Top 3 leading cancers (ranked by
deaths) Lung
Liver Colorectum
Breast Cervix uteri Ovary
Lung Liver Breast
Prevalence
5-year prevalent cases 397 985 620 125 1 018 110
*
**
*
**
*
0 250 500 1000 Kilometers
Indonesia
**
Males
Lung
Colorectum
Liver
Nasopharynx Prostate Others
Total: 188 395
Number of new cases in 2022, males, all ages
Rank Cancer site Number of cases Percent
1st Lung 29 107 15.4%
2nd Colorectum 21 903 11.6%
3rd Liver 18 314 9.7%
4th Nasopharynx 14 497 7.7%
5th Prostate 13 130 7.0%
- Others 91 444 48.5%
Females
Breast
Cervix uteri
Ovary Colorectum Lung Others
Total: 220 266
Number of new cases in 2022, females, all ages
Rank Cancer site Number of cases Percent
1st Breast 66 271 30.1%
2nd Cervix uteri 36 964 16.8%
3rd Ovary 15 130 6.9%
4th Colorectum 13 773 6.3%
5th Lung 9 797 4.4%
- Others 78 331 35.6%
Both sexes
Breast
Lung
Cervix uteri
Colorectum Liver Others
Total: 408 661
Number of new cases in 2022, both sexes, all ages
Rank Cancer site Number of cases Percent
1st Breast 66 271 16.2%
2nd Lung 38 904 9.5%
3rd Cervix uteri 36 964 9.0%
4th Colorectum 35 676 8.7%
5th Liver 23 805 5.8%
- Others 207 041 50.7%
The Global Cancer Observatory | All rights reserved | Globocan 2022 - 08.02.2024 Page 1
G L O B O C A N 2 0 2 2
INDONESIA
New cases Deaths 5-year prevalence
Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)
Breast 66 271 1 16.2 4.4 22 598 3 9.3 1.6 209 748 20.6
Lung 38 904 2 9.5 1.6 34 339 1 14.1 1.5 51 194 5.0
Cervix uteri 36 964 3 9.0 2.4 20 708 4 8.5 1.5 120 940 11.9
Colorectum 35 676 4 8.7 1.4 19 255 5 7.9 0.71 104 235 10.2
Liver 23 805 5 5.8 0.92 23 383 2 9.6 0.91 30 363 3.0
Nasopharynx 18 835 6 4.6 0.70 12 949 6 5.3 0.53 54 281 5.3
NHL 16 175 7 4.0 0.61 9 440 9 3.9 0.36 50 496 5.0
Ovary 15 130 8 3.7 1.0 9 673 8 4.0 0.71 45 711 4.5
Leukaemia 13 959 9 3.4 0.43 10 370 7 4.3 0.34 42 867 4.2
Thyroid 13 761 10 3.4 0.45 2 141 19 0.88 0.07 43 354 4.3
Prostate 13 130 11 3.2 1.2 4 860 12 2.0 0.31 33 051 3.2
Corpus uteri 8 384 12 2.1 0.59 2 454 18 1.0 0.17 29 904 2.9
Bladder 7 381 13 1.8 0.30 3 207 15 1.3 0.11 21 376 2.1
Lip, oral cavity 6 515 14 1.6 0.25 3 546 13 1.5 0.13 16 573 1.6
Brain CNS 5 738 15 1.4 0.18 5 259 11 2.2 0.18 20 134 2.0
Pancreas 5 734 16 1.4 0.24 5 833 10 2.4 0.24 5 781 0.57
Larynx 4 000 17 0.98 0.16 2 525 17 1.0 0.10 10 315 1.0
Stomach 3 852 18 0.94 0.13 3 242 14 1.3 0.11 5 308 0.52
Multiple myeloma 3 289 19 0.81 0.14 2 948 16 1.2 0.12 8 490 0.83
Kidney 2 676 20 0.66 0.11 1 563 20 0.64 0.07 7 459 0.73
Salivary glands 2 436 21 0.60 0.09 1 083 22 0.45 0.04 7 930 0.78
Melanoma 1 716 22 0.42 0.06 774 24 0.32 0.03 5 245 0.52
Oropharynx 1 525 23 0.37 0.05 892 23 0.37 0.03 4 080 0.40
Testis 1 492 24 0.37 0.07 342 29 0.14 0.01 5 368 0.53
Oesophagus 1 382 25 0.34 0.06 1 330 21 0.55 0.06 1 931 0.19
Vulva 1 307 26 0.32 0.09 470 25 0.19 0.03 3 342 0.33
Hodgkin lymphoma 1 294 27 0.32 0.04 373 28 0.15 0.01 4 541 0.45
Penis 1 098 28 0.27 0.08 419 27 0.17 0.03 2 935 0.29
Gallbladder 627 29 0.15 0.02 432 26 0.18 0.01 697 0.07
Vagina 462 30 0.11 0.02 189 31 0.08 0.01 989 0.10
Hypopharynx 292 31 0.07 0.01 160 32 0.07 0.01 555 0.06
Mesothelioma 243 32 0.06 0.01 227 30 0.09 0.01 197 0.02
All cancers 408 661 - - 14.0 242 988 - - 8.8 1 018 110 -
All cancers excl. NMSC 400 820 - - 13.7 240 537 - - 8.7 993 577 -
Incidence, Mortality and Prevalence by cancer site
Data source and methods
Incidence
Country-specific data source: No data
Method: No data: the rates are those of neighbouring countries or registries in the same area
Mortality
Country-specific data source: No data
Method: Estimated from national mortality estimates by modelling, using mortality:incidence ratios derived from survival estimation
Prevalence
Computed using sex-; site- and age-specific incidence to 1-;3- and 5-year prevalence ratios from Nordic countries for the period (2011-2020), and scaled using Human Development Index (HDI) ratios.
41.8 23.3
13.4 12.1 10.5
9.8 8.0
6.1 5.5 5.3 5.2 4.5 2.6
2.2 2.0
0 10 20 30 40 50 60 Breast Cervix uteri Lung Colorectum Prostate Ovary Liver Nasopharynx NHL Corpus uteri Leukaemia Thyroid Bladder Lip, oral cavity Brain CNS
0 10 20 30 40 50 60 14.4
13.2 11.9 6.6 4.2
6.2 7.9 4.3 3.3 1.6
3.7 0.8 1.1 1.2 1.8 Incidence Mortality
ASR (World) incidence and mortality rates, top 15 cancers**
21.3 15.7
12.9 10.5
9.6 7.3 6.4
4.7 2.9 2.8 2.7
0 10 20 30 40 50 Breast Cervix uteri Lung Colorectum Liver Prostate Ovary Nasopharynx NHL Leukaemia Corpus uteri Bladder Lip, oral cavity Thyroid Larynx
0 10 20 30 40 50
41.8 23.3
6.4 8.9 3.6
9.8 2.8
3.9 4.0 5.3 0.7
1.6 6.2 0.2 Males Females
ASR (World) incidence rates per sex, top 15 cancers**
* includes non-melanoma skin cancer (NMSC)
** NMSC included in other cancers
Age standardization using world population (see link)
References
Website citation
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).
Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today
Page 2